ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
Tesamorelin vs. Ipamorelin?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Cataceous" data-source="post: 172764" data-attributes="member: 38109"><p>And yet your own reference showed that the positive effects of <strong>lower</strong> IGF-1 are widely accepted. The first words of the abstract:</p><p></p><p style="margin-left: 20px"><em><strong>Diminished growth factor signaling improves longevity in laboratory models, while a reduction in the somatotropic axis is favorably linked to human aging and longevity.</strong> Given the conserved role of this pathway on lifespan, therapeutic strategies, such as insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibodies (mAb), represent a promising translational tool to target human aging.</em></p> <p style="margin-left: 20px"></p><p>Sorry, not going to wade through a video. Quote some published studies.</p><p></p><p>In general summary articles what's being argued is that while higher IGF-1 does cause problems, <em>maybe</em> we can work around that by providing artificial stressors via diet to mimic the effects of lower IGF-1.</p></blockquote><p></p>
[QUOTE="Cataceous, post: 172764, member: 38109"] And yet your own reference showed that the positive effects of [B]lower[/B] IGF-1 are widely accepted. The first words of the abstract: [INDENT][I][B]Diminished growth factor signaling improves longevity in laboratory models, while a reduction in the somatotropic axis is favorably linked to human aging and longevity.[/B] Given the conserved role of this pathway on lifespan, therapeutic strategies, such as insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibodies (mAb), represent a promising translational tool to target human aging.[/I][/INDENT] [INDENT][/INDENT] Sorry, not going to wade through a video. Quote some published studies. In general summary articles what's being argued is that while higher IGF-1 does cause problems, [I]maybe[/I] we can work around that by providing artificial stressors via diet to mimic the effects of lower IGF-1. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
Tesamorelin vs. Ipamorelin?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top